These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16088980)

  • 1. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1211-6. PubMed ID: 17853493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems with practolol.
    Wall-Manning HJ
    Drugs; 1975; 10(5-6):336-41. PubMed ID: 1240
    [No Abstract]   [Full Text] [Related]  

  • 4. Practolol and the safety of other beta blockers.
    Sutherland DC; Wilson JD
    N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
    Amos HE; Lake BG; Artis J
    Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug eruptions caused by beta-blockers].
    Bonnetblanc JM
    Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oculocutaneous reactions following treatment with betablockers].
    Erikssen J
    Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Skin reactions due to practolol].
    Marghescu S
    Hautarzt; 1975 Dec; 26(12):663. PubMed ID: 1213887
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
    Behan PO; Behan WM; Zacharias FJ; Nicholls JT
    Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
    Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E
    Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Ocular reactions to beta-blockers.
    Lyall JR
    Br Med J; 1975 Jun; 2(5973):747. PubMed ID: 237597
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Beta-blockers and the eye.
    Br J Ophthalmol; 1976 May; 60(5):311. PubMed ID: 8075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adrenergic beta receptor blockaders].
    Naess K
    Tidsskr Nor Laegeforen; 1975 Feb; 95(6):380-3. PubMed ID: 235805
    [No Abstract]   [Full Text] [Related]  

  • 14. [From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy].
    Lunde I; Borchgrevink CF
    Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1609. PubMed ID: 1179394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Betablockers and skin (author's transl)].
    Bonnetblanc JM; Roux J
    Ann Dermatol Venereol; 1979 Nov; 106(11):927-30. PubMed ID: 44166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ; Beeley L
    Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reaction to the beta-adrenergic blocking drugs.
    Brigden WD; Almeyda J
    Br J Dermatol; 1976 Sep; 95(3):335-8. PubMed ID: 974021
    [No Abstract]   [Full Text] [Related]  

  • 18. Practolol and the nephrotic syndrome.
    Farr MJ; Wingate JP; Shaw JN
    Br Med J; 1975 Apr; 2(5962):68-9. PubMed ID: 1131550
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms.
    Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT
    Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing times: the emergence of the practolol disaster and its challenge to British drug regulation in the modern period.
    Abraham J; Davis C
    Soc Hist Med; 2006 Apr; 19(1):127-47. PubMed ID: 17153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.